期刊文献+

5种终末期肝病模型判断原发性肝癌患者预后的比较 被引量:3

Comparison of five models for end-stage liver disease to predict the prognosis of patients with primary hepatic cancer
下载PDF
导出
摘要 目的评价终末期肝病模型(MELD)及其联合血清钠相关模型判断原发性肝癌(PHC)患者预后的能力,包括终末期肝病血清钠模型(MELD-Na)、终末期肝病血清钠腹水模型(MELD-AS)、终末期肝病血清钠年龄模型(iMELD)和终末期肝病血清钠值比模型(MESO)。方法回顾性分析300例PHC患者资料。采用受试者工作特征曲线及曲线下面积(AUC)评价5种模型判断患者预后的能力;不同患者生存率的差异采用Kaplan-Meier方法的Log-rank检验进行计算。结果判断患者3、12个月的预后,MELD-AS的AUC最大(0.793和0.639),与其余各模型的AUC差异均有统计学意义;MELD、MELD-Na、MELD-AS、iMELD、MESO的最佳截值点分别为5.0、5.0、6.0、21.0和0.4,以此截值点对患者进行分组,各模型高低分值组间患者的生存率均有显著性差异(P<0.001)。结论 5种终末期肝病模型均可作为判断原发性肝癌患者预后的指标,以MELD-AS判断患者中短期预后能力最佳。 Objective To investigate the prognostic accuracy of the model for end-stage liver disease(MELD) and four new MELD-based models combination with serum sodium in primary hepatic cancer(PHC) patients-the MELD with the incorporation of serum sodium(MELD-Na), incorporating MELD,persistent ascites and low serum sodium(MELD-AS),the integrated MELD including serum sodium and age(iMELD),and the MELD to sodium index(MESO).Methods A total of 300 patients with PHC were enrolled into the study.MELD,MELD-Na,MELD-AS, iMELD and MESO scores were calculated for each patient following the original formula on the first day of admission.All patients were followed up at least 1 year.The predictive prognosis related with the five models was determined by the area under the receiver operating characteristic curve(AUC).Kaplan-Meier survival curves were made using the cut-offs identified by means of receiver operating characteristic(ROC).Results The MELD-AS had the highest AUC(0.793) 3 months after the enrollment,and was followed by the MELD(0.742),MELD-Na(0.741),iMELD (0.729) and MESO(0.727).The difference between the MELD-AS score and each of the other MELD scores was statistically significant(all P0.04);12 month after enrollment,the MELD-AS had the highest AUC(0.639),and was followed by the iMELD(0.615),MELD-Na(0.613),MELD (0.608) and MESO(0.604).The difference between the MELD-AS score and each of the other MELD scores was statistically significant except for iMELD(P=0.357).The most discriminative cut-offs from the ROC with the z-statistic for MELD,MELD-Na,MELD-AS,iMELD and MESO were 5.0,5.0,6.0,21.0 and 0.4 at 3 month of enrollment.Survival curves showed that the MELD and four new MELD-based models were all clearly discriminated the patients who survived or died in short-term as well as intermediate-term(P0.001) according to these cut-offs.Conclusion MELD and four new MELD-based models,changed with serum sodium(MELD-Na,MELDAS, iMELD and MESO),can exactly predict the prognosis of patients with PHC in short and intermediate period.The MELD-AS may be the best prognostic model for outcome prediction in patients with PHC of the five MELD-based models.
作者 文洁 朱德增
出处 《兰州大学学报(医学版)》 CAS 2010年第4期68-72,共5页 Journal of Lanzhou University(Medical Sciences)
关键词 肝肿瘤 预后模型 终末期肝病模型 liver neoplasms prognostic model model for end-stage liver disease
  • 相关文献

参考文献12

  • 1KAMATH P S,WIESNER R H,MALINCHOC M,et al.A model to predict survival in patients with endstage liver disease[J].Hepatology,2001,33(2):464-470.
  • 2PUOH R N,MURRAY-LYON I M,DAWSON J L,et al.Transection of the oesophagus for bleeding oesophageal varices[J].Br J Surg,1973,60(8):646-649.
  • 3FREEMAN R B,WIESNER R H,HARPER A,et al.The new liver allocation system:moving toward evidence-based transplantation policy[J].Liver Transpl,2002,8(9):851-858.
  • 4杨明兆,韩文静,宋青辉.肝硬化并低钠血症的临床分析及预后[J].中华医学丛刊,2004,4(1):48-49. 被引量:1
  • 5BIGGINS S W,KIM W R,TERRAULT N A,et al.Evidence-based incorporation of serum sodium concentration into MELD[J].Gastroenterology,2006,130(6):1652-1660.
  • 6HEUMAN D M,ABOUASSl S G,HABIB A,et al.Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death[J].Hepatology,2004,40(4):802-810.
  • 7LUCA A,AANERMAYR B,BERTOLINI G,et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J].Liver Transplantation,2007,13(8):1174-1180.
  • 8Huo Teh-la,WANG Ying-wen,YANG Ying-ying,et al.Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J].Liver International,2007,27(4):498-506.
  • 9杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准[J].肿瘤防治研究,2002,29(1):83-83. 被引量:117
  • 10樊景云,黄宗文,郭佳.4项评分系统对重症急性胰腺炎预后评估的受试者工作特征曲线分析[J].中西医结合学报,2009,7(1):34-40. 被引量:22

二级参考文献60

共引文献140

同被引文献39

  • 1沈美龙,徐洪涛,邢同京,咸建春,韩立彬,王开林,李浩.终末期肝病模型联合白细胞介素15评分对慢性乙型肝炎预后预测[J].中华临床医师杂志(电子版),2011,5(21):6358-6362. 被引量:4
  • 2Sheng, Qin-Song,Lang, Ren,He, Qiang,Yang, Yong-Jiu,Zhao, De-Fang,Chen, Da-Zhi.Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2009,8(1):46-49. 被引量:37
  • 3李自微.肝病血清蛋白电泳谱分析[J].中西医结合肝病杂志,2005,15(1):45-46. 被引量:8
  • 4张俊勇,刘吉勇,张福奎,王宝恩,贾继东.终末期肝病模型判断原发性肝癌患者预后的价值[J].中华肿瘤防治杂志,2007,14(4):297-299. 被引量:7
  • 5PUGH R N, MURRAY-LYON I M, DAWSON J L, et al. Transection of the oesophagus for bleeding oe- sophageal varices[J]. Br J Surg, 1973, 60(8): 646- 649.
  • 6KAMATH P S, WIESNER R H, MALINCHOC M, et al. A model to predict survival in patients with end- stage liver disease[J]. Hepatology, 2001, 33(2): 464- 470.
  • 7CUCCHETTI A, ERCOLANI G, VIVARELLI M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocel- lular carcinoma on cirrhosis[J]. Liver Transpl,2006, 12(6): 966-971.
  • 8Huo. Teh-ia, LEE Pui-ching, HUANG Yi-hsiang, et al. The sequential changes of tile model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular car- cinoma undergoing locoregional therapy[J]. J Clin Gastroenterol, 2006, 40(6): 543-550.
  • 9SHARMA P, BALAN V, HERNANDEZ J L, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact[J]. Liver Transpl, 2004, 10(1): 36- 41.
  • 10WIESNER R H, FREEMAN R B, MULLIGAN D C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy[J]. Gastroen- terology, 2004, 127(5 Suppl 1): 261-267.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部